Dynamic View on Affordability of Fixed-Dose Combination Antihypertensive Drug Therapy.

CONCLUSIONS: The cost advantage of FDCs over FCs was reversed when FCs were generically available. The finding of this study informs patients, health-care providers, and drug plans of the importance of making dynamic decisions on preferred drug therapy options depending on the availability of generic drugs. PMID: 23512697 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23512697?dopt=Abstract

Source: American Journal of Hypertension - March 18, 2013 Category: Cardiology Authors: Hong SH, Wang J, Tang J Tags: Am J Hypertens Source Type: research